Amniotic fluid stem cells: A novel treatment for necrotizing enterocolitis

Area of Science:

• Regenerative Medicine
• Neonatal Gastroenterology
• Stem Cell Biology

Background:

• Necrotizing enterocolitis (NEC) is a severe gastrointestinal disease affecting premature neonates.
• Current diagnostic methods for NEC lack accuracy, and existing treatments are limited.
• There is a critical need for novel therapeutic strategies for NEC.

Purpose of the Study:

• To review the regenerative medical literature on treating NEC.
• To evaluate the potential protective and restorative effects of amniotic fluid stem cells (AFSCs) on NEC-induced intestinal injury.
• To explore the mechanisms of AFSC action, including Wnt-dependent pathways.

Main Methods:

• Comprehensive review of existing scientific literature on AFSCs and NEC.
• Analysis of AFSC components, including conditioned medium (CM) and extracellular vesicles (EVs).
• Investigation into the Wnt-dependent signaling pathway involved in AFSC-mediated protection.

Main Results:

• AFSCs demonstrate significant protective and restorative potential against NEC-induced intestinal damage.
• Comparison of different AFSC components (CM, EVs) highlights their therapeutic contributions.
• Identification of a novel Wnt-dependent mechanism underlying AFSC protection in NEC.

Conclusions:

• AFSCs and their derivatives represent a promising therapeutic avenue for NEC.
• Further research is needed to address knowledge gaps for clinical translation of AFSC-based therapies.
• Understanding AFSC mechanisms, including Wnt signaling, is crucial for optimizing NEC treatment.